Both mAbs inhibited lymphoma growth in xenogeneic murine models via a mechanism that did not involve a direct cytotoxic effect on the tumor cells, but rather seemed to be a result of neutralization of heparanase activity in the tumor microenvironment. This evidence concerns the gene HPSE and neoplasm.